Overview

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity

Status:
COMPLETED
Trial end date:
2024-12-23
Target enrollment:
Participant gender:
Summary
The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and efficacy of THDBH120 injection in participants with obesity. This study includes three multiple-ascending dose cohorts.
Phase:
PHASE1
Details
Lead Sponsor:
Tonghua Dongbao Pharmaceutical Co.,Ltd